title: [Modification of perioperative drug therapy in cardiovascular, pulmonary or metabolic disease].
abstract: Almost 50 % of all patients that are evaluated preoperatively by an anesthesiologist are receiving concurrent medication. Many of the prescribed drugs can be omitted during the perioperative period. However, perioperative cessation of certain drug therapies may cause decompensation of primarily compensated diseases. After reading this CME article, the reader should be able to decide whether any cardiovascular, pulmonary or antidiabetic drug therapy should be continued or ceased during the perioperative period, respectively.
authors.affiliation: Klinik und Poliklinik für Anästhesiologie, Universitätsklinikum Würzburg. Redel_A@klinik.uni-wuerzburg.de
authors.forename: Andreas
authors.initials: A
authors.lastname: Redel
authors.forename: Ulrich
authors.initials: U
authors.lastname: Schwemmer
mesh_terms: D000758:Anesthesia / Q000379:methods*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D005858:Germany; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008659:Metabolic Diseases / Q000188:drug therapy*; D019990:Perioperative Care / Q000379:methods*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011292:Premedication / Q000379:methods*; D011785:Quality Assurance, Health Care